Analyses of apoptotic regulators CASP9 and DFFA at 1p36.2, reveal rare allele variants in human neuroblastoma tumours

British Journal of Cancer

Volumn 86, Issue 4, 2002, Pages 596-604

  Abel, F ^a   Sjoberg R M ^a   Ejeskar K ^a   Krona, C ^a   Martinsson, T ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

1p deletion; Apaf 3; DFF; ICAD; Neuroblastoma; Neuroectodermal

Indexed keywords

CASPASE 9; DEOXYRIBONUCLEASE; GENE PRODUCT; PROTEIN DFFA; UNCLASSIFIED DRUG;

ALLELISM; AMINO ACID SUBSTITUTION; APOPTOSIS; ARTICLE; CANCER STAGING; CARCINOGENESIS; CHROMOSOME MAP; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; GENE DELETION; GENE LOCUS; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

ALLELES; AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CASE-CONTROL STUDIES; CASPASE 9; CASPASES; CHROMOSOMES, HUMAN, PAIR 1; CLONING, MOLECULAR; DNA MUTATIONAL ANALYSIS; DNA PRIMERS; DNA, NEOPLASM; GENE FREQUENCY; GENES, TUMOR SUPPRESSOR; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM PROTEINS; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROTEINS;

EID: 0037065960     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600111     Document Type: Article

References (42)

1. Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24
2. Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma
3. Neuroblastoma: Clinical significance of genetic abnormalities
4. Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment
5. Regulation of cell death protease caspase-9 by phosphorylation
6. Evidence for two tumour suppressor loci on chromosomal bands 1p35-36 involved in neuroblastoma: One probably imprinted, another associated with N-myc amplification
7. Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors
8. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours
9. Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development
10. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD
11. Duplication of the DR3 gene on human chromosome 1p36 and its deletion in human neuroblastoma
12. Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40
13. Genomic organization of the human caspase-9 gene on Chromosome 1p36-36.3
14. Differential requirement for caspase 9 in apoptotic pathways in vivo
15. CPAN, a human nuclease regulated by the caspase-sensitive inhibitor DFF45
16. The CARD domain: A new apoptotic signalling motif
17. Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas
18. Bcl-2 oncoprotein expression and apoptosis in neuroblastoma
19. Interleukin-1 beta converting enzyme (ICE) is preferentially expressed in neuroblastomas with favourable prognosis
20. Structure and mutation analysis of the gene encoding DNA fragmentation factor 40 (caspase-activated nuclease), a candidate neuroblastoma tumour suppressor gene
21. Structure and promoter analysis of murine CAD and ICAD genes
22. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9
23. Assignment of the DNA fragmentation factor gene (DFFA) to human chromosome bands 1p36.3-,gt;p36.2 by in situ hybridization
24. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
25. The 40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and chromatin condensation during apoptosis
26. DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis
27. Human Kruppel-related 3 (HKR3): A candidate for the 1p36 neuroblastoma tumour suppressor gene?
28. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours
29. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms
30. Study of bcl-2 protein expression and the apoptosis phenomenon in neuroblastoma
31. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-36.3 in a neuroblastoma cell line
32. Cleavage of CAD inhibitor in CAD activation and DNA degradation during apoptosis
33. Specific chaperone-like activity of inhibitor of caspase-activated DNase for caspase-activated
34. Auto-activation of procaspase-9 by Apaf-1-mediated oligomerization
35. The Ced-3/interleukin 1beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32
36. There may be two tumor suppressor genes on chromosome arm 1p closely associated with biologically distinct subtypes of neuroblastoma
37. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN
38. A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3
39. Resistance to DNA fragmentation and chromatin condensation in mice lacking the DNA fragmentation factor 45
40. DNA fragmentation factor 45-deficient cells are more resistant to apoptosis and exhibit different dying morphology than wild-type control cells
41. Solution structure of DFF40 and DF45 N-terminal domain complex and mutual chaperone activiny of DFF40 and DFF45
42. Solution structure of Apaf-1 CARD and its interaction with caspase-9 CARD: A structural basis for specific adaptor/caspase interaction